TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Pericarditis
Reports from C.S. Wiysonge et al highlight recent research in pericarditis
May 20th, 2008
According to recent research from Cape Town, South Africa, "There is controversy concerning the effectiveness of adjunctive corticosteroids in reducing mortality in tuberculous pericarditis. To assess the impact of this controversy on contemporary clinical practice, we studied the use of adjunctive corticosteroid in 185 consecutive patients with suspected pericardial tuberculosis from 15 hospitals in Cameroon, Nigeria, and South Africa. 109 (58.9%) patients received steroids with significant variation in corticosteroid use ranging from 0% to 93.5% per centre (P <0.0001)." "The presence of clinical features of HIV infection was the independent predictor of the non-use...
Source: TB & Outbreaks Week (2008-05-20)
|
